7月28日，施贵宝盘中上涨3.05%，报64.675美元/股，成交额1.66亿美元。
消息面上，公司近期宣布扩大与英伟达的合作，将部署基于Vera Rubin全新架构的DGX SuperPOD超算系统，打造制药行业"最强大的"AI超级计算机，用于加速新药靶点挖掘与临床研发，成为全球首家落地该设备的生命科学企业。此外，公司此前已先后与Anthropic、Tempus AI等达成AI战略合作，全面推进AI在药物研发全流程中的应用。
同时，公司将于7月30日盘前发布季度财报（预期EPS为1.59美元），市场情绪偏暖。制药板块整体走强，辉瑞涨3.06%，默沙东涨3.01%，强生涨2.56%，礼来涨2.66%，阿斯利康涨2.14%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.